Next Issue

May 2024

Don’t miss out – sign up to our free industry-leading magazine and newsletters

In the next issue, we will explore the real-world experience of rolling out RSV vaccines, how continuous monitoring can expand aseptic knowledge, and more.

EDITORIAL

Editor |Manasi Vaidya, Irena Maragkou

Writers | Robert Barrie, Natasha Spencer-Jolliffe, Sally Turner, Irena Maragkou

Graphic Designers | Anett Arc, Noemi Balint, Will Ingham, Miriam Garofalo

Publisher | Susanne Hauner

ADVERTISING

Sales Manager | Tom McCormick
+44 207 8669440

Pharma Technology Focus is powered by H5mag
Read past issues of Pharma Technology Focushere

Go to article: Home | What’s next for AAV gene therapies in 2024?Go to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: phasetwoGo to article: Avenga Company InsightGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Trends & InsightGo to article: Datwyler Company InsightGo to article: DatwylerGo to article: Zenatek Company InsightGo to article: Simtra BioPharma SolutionsGo to article: In DepthGo to article: What’s Next for AAV Gene Therapies in 2024?Go to article: Traceability technologies tighten supply chain fakeryGo to article: Switching sales: Investigating the financial impacts of FDA’s priority vouchersGo to article: Is HIV-TB coinfection treatment entering a new frontier?Go to article: Patient organisations need to tackle transparency Go to article: AD/PD 2024: Eli Lilly’s donanemab hit with FDA delay Go to article: Q&A: Increasing awareness around digital therapeutics key to realising full potentialGo to article: Sponsored SupplementsGo to article: Lactalis IngredientsGo to article: BEA TechnologiesGo to article: ListingsGo to article: EventsGo to article: Innovation RankingsGo to article: Buyer's GuidesGo to article: Next issue